We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
VP31.03: Endotheliopathy biomarkers and angiogenic factors in distinguishing pre‐eclampsia from COVID‐19 in pregnancy.
- Authors
Youssef, L.; Palomo, M.; Fernandez, S.; Torramade‐Moix, S.; Moreno‐Castaño, A.; Martinez‐Sanchez, J.; Ramos, A.; Bonastre, L.; Pino, M.; Gomez‐Ramirez, P.; Sanchez, P.; Crovetto, F.; Escolar, G.; Carreras, E.; Castro, P.; Gratacos, E.; Diaz‐Ricart, M.; Crispi, F.
- Abstract
To explore the performance of endotheliopathy biomarkers and angiogenic factors in distinguishing pre-eclampsia (PE) from COVID-19 in pregnancy. Conclusions PE could be distinguished from COVID-19 by sFlt1/PlGF ratio and other endotheliopathy biomarkers. VP31.03: Endotheliopathy biomarkers and angiogenic factors in distinguishing pre-eclampsia from COVID-19 in pregnancy.
- Subjects
VASCULAR endothelial growth factors; COVID-19; PREECLAMPSIA; BIOMARKERS; PLACENTAL growth factor
- Publication
Ultrasound in Obstetrics & Gynecology, 2021, Vol 58, p225
- ISSN
0960-7692
- Publication type
Article
- DOI
10.1002/uog.24468